title: Chemoimmunotherapy as a new standard of care for Burkitt leukaemia/lymphoma.
authors.affiliation: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: ejabbour@mdanderson.org.
authors.forename: Elias
authors.initials: E
authors.lastname: Jabbour
authors.affiliation: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D000069283:Rituximab / Q000008:administration & dosage*
chemical_list: D014408:Biomarkers, Tumor; D000069283:Rituximab